C WorldWide Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-158,996
Closed -$2.58M 137
2018
Q3
$2.58M Sell
158,996
-5,077
-3% -$72.6K 0.03% 87
2018
Q2
$2.12M Buy
164,073
+33,059
+25% +$447K 0.03% 93
2018
Q1
$1.63M Sell
131,014
-22,886
-15% -$279K 0.03% 86
2017
Q4
$2.15M Sell
153,900
-29,335
-16% -$430K 0.03% 83
2017
Q3
$3.08M Buy
183,235
+1,087
+0.6% +$17.7K 0.04% 78
2017
Q2
$3.06M Buy
182,148
+6,030
+3% +$90.1K 0.05% 79
2017
Q1
$2.73M Buy
176,118
+16,118
+10% +$230K 0.05% 78
2016
Q4
$2.39M Sell
160,000
-40,000
-20% -$562K 0.05% 76
2016
Q3
$2.51M Buy
200,000
+129,540
+184% +$1.3M 0.04% 82
2016
Q2
$634K Hold
70,460
0.01% 105
2016
Q1
$698K Hold
70,460
0.01% 106
2015
Q4
$837K Sell
70,460
-50,000
-42% -$619K 0.01% 113
2015
Q3
$1.63M Hold
120,460
0.03% 90
2015
Q2
$1.67M Hold
120,460
0.02% 94
2015
Q1
$1.7M Buy
120,460
+20,000
+20% +$272K 0.02% 87
2014
Q4
$1.37M Buy
100,460
+40,460
+67% +$553K 0.02% 81
2014
Q3
$898K Buy
+60,000
New +$919K 0.01% 93

Other funds holding OXFD

C WorldWide Group's OXFD Position: Q4 2018 in Review

C WorldWide Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2018, closing a stake of 158,996 shares — an estimated $2.58M sold.

C WorldWide Group first reported a position in OXFD in Q3 2014 and held it in 17 quarters. The position peaked at $3.08M in Q3 2017. 82 funds tracked by Wall St. Rank hold OXFD as of Q4 2018.

  • C WorldWide Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • C WorldWide Group sold 158,996 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2018, an estimated $2.58M.
  • C WorldWide Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2014 and held it in 17 quarters.
  • C WorldWide Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $3.08M in Q3 2017.
  • 82 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2018.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.